Benefits Vitamin B12 Tabs
Key Findings
1000 µg/day of oral methylcobalamin significantly improved neuropathic parameters, sudomotor function, pain scores, and quality of life in patients with diabetic neuropathy over 12 months [1].
Daily supplementation with 1000 µg or 2000 µg of oral methylcobalamin for 16 weeks similarly improved neuropathic symptoms in patients with diabetic peripheral neuropathy and low serum vitamin B12, with no additional benefits observed for the higher dose beyond increased serum B12 levels [2].
Sublingual methylcobalamin at 1000 µg/day for 6 months is suggested for treating recurrent aphthous stomatitis, showing significant reductions in outbreaks, number, and duration of ulcers [3].
Introduction
Methylcobalamin is an active coenzyme form of vitamin B12 that plays a critical role in nervous system maintenance, DNA and protein methylation, and various metabolic and therapeutic applications [4] [5]. This report discusses the health benefits of 1000 µg methylcobalamin supplementation, drawing from recent clinical studies.
Main Text
Benefits in Neurological Conditions
A 1-year, randomized, double-blind, placebo-controlled trial involving 90 patients with type 2 diabetes on metformin and both peripheral and autonomic diabetic neuropathy, who had B12 levels less than 400 pmol/L, found that oral methylcobalamin 1000 µg/day significantly improved sural nerve conduction velocity, sural nerve action potential, vibration perception threshold, Michigan Neuropathy Screening Instrument Questionnaire scores, quality of life, pain scores, and electrochemical skin conductance in feet [1]. However, cardiovascular autonomic reflex tests and Michigan Neuropathy Screening Instrument Examination scores did not significantly improve [1].
A 16-week randomized controlled trial comparing 1000 µg and 2000 µg daily oral methylcobalamin in adults with type 2 diabetes, diabetic peripheral neuropathy, and low serum vitamin B12 (<200 pg/mL), showed that both doses significantly improved neuropathy symptoms, as measured by the numerical rating scale and Michigan Neuropathy Screening Instrument Examination scores. No significant difference in neuropathic outcomes was observed between the two doses [2].
Methylcobalamin facilitates neurite outgrowth and inhibits neural apoptosis through the Erk1/2 and Akt signaling pathways, and high doses have shown to ameliorate symptoms and negative electrophysiological findings in animal models of peripheral nerve neuropathy and in patients with carpal tunnel syndrome and amyotrophic lateral sclerosis [5] [6].
Other Therapeutic Applications
A review of randomized controlled trials suggests that a daily dose of 1000 µg of sublingual vitamin B12 (methylcobalamin) for 6 months can significantly reduce outbreaks, number, and duration of ulcers in recurrent aphthous stomatitis [3].
In a randomized double-blind placebo-controlled pilot study, oral methylcobalamin reduced mean baseline plasma total homocysteine from 15.5 µmolL-1 to 8.4 µmolL-1 in vitamin B12 deficient vegetarians, potentially reducing the risk of cardiovascular disease [7].
A multicenter, randomized controlled trial found that a dispersible supplement containing 1000 µg of B12 along with vitamin D improved serum B12 levels in individuals with combined deficiencies [8].
A study comparing sublingual methylcobalamin (1 puff/day for children under 8 years or 2 puffs/day for those 8 years and older) with intramuscular cyanocobalamin for 3 months in children with vitamin B12 deficiency found both methods equally effective in increasing serum B12 levels [9].
Conclusion
Supplementation with 1000 µg of methylcobalamin has demonstrated significant health benefits across various conditions. It effectively improves neuropathic symptoms, sudomotor function, pain, and quality of life in diabetic neuropathy patients [1] [2]. Furthermore, it shows promise in treating recurrent aphthous stomatitis by reducing ulcer outbreaks and duration [3], and in normalizing elevated homocysteine levels in vitamin B12 deficient vegetarians, thereby potentially lowering cardiovascular disease risk [7]. The evidence suggests that 1000 µg of methylcobalamin is a beneficial dose with various therapeutic applications.
References:
1) T Didangelos et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients (2021). https://pubmed.ncbi.nlm.nih.gov/33513879/
2) A Mansour et al. Efficacy of Oral Vitamin B-12 at 1000 μg Compared with 2000 μg on Neuropathic Outcomes in Patients with Diabetic Peripheral Neuropathy and Low Serum Vitamin B-12: a Randomized Clinical Trial. The Journal of nutrition (2026). https://pubmed.ncbi.nlm.nih.gov/41548600/
3) R Taleb et al. Role of vitamin B12 in treating recurrent aphthous stomatitis: A review. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition (2020). https://pubmed.ncbi.nlm.nih.gov/33103958/
4) Methylcobalamin. Alternative medicine review : a journal of clinical therapeutic (1998). https://pubmed.ncbi.nlm.nih.gov/9855571/
5) H Tanaka et al. [Old or new medicine? Vitamin B12 and peripheral nerve neuropathy]. Brain and nerve = Shinkei kenkyu no shinpo (2013). https://pubmed.ncbi.nlm.nih.gov/24018744/
6) K Okada et al. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Experimental neurology (2010). https://pubmed.ncbi.nlm.nih.gov/20045411/
7) D Obersby et al. Efficacy of Methylcobalamin to Normalise Elevated Homocysteine of Vitamin B12 Deficient Vegetarians: A Double Blind Placebo Control Study. Current Research in Nutrition and Food Science Journal (2015). https://doi.org/10.12944/crnfsj.3.3.02/
8) N Angelopoulos et al. Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg of B12 in Restoring Vitamin D and B12 Insufficiency: A Multicenter, Randomized Controlled Trial. Nutrients (2025). https://pubmed.ncbi.nlm.nih.gov/39940277/
9) S Aydin et al. Evaluation of a New Sublingual Methylcobalamin Dosage Regimen for Childhood Vitamin B12 Deficiency. Children (Basel, Switzerland) (2025). https://pubmed.ncbi.nlm.nih.gov/40310078/